Bill > SB0236

This bill modifies the definitions of "abortion" and "abortion-inducing drug" to clarify what constitutes an abortion and what substances are considered abortion-inducing drugs, including specific examples like mifepristone and misoprostol. It also expands the reporting requirements for abortion complications to include where the abortion occurred (in or out of Indiana) and the location where treatment for the complication was received, and mandates that these reports be sent to the office of the inspector general. Crucially, the bill introduces significant liability for those who manufacture, distribute, mail, transport, deliver, prescribe, or provide abortion-inducing drugs, making them jointly and severally liable for any wrongful death or personal injury to an unborn child or pregnant woman resulting from their use, and allows the mother or father of an unborn child to bring a wrongful death lawsuit. Furthermore, it establishes new legal avenues for civil actions, including wrongful death and qui tam (whistleblower) actions, against those involved with abortion-inducing drugs, while also outlining specific affirmative defenses and exceptions. The bill also makes changes to existing laws regarding informed consent brochures, physician admitting privileges, and the disposal of aborted fetuses, and includes provisions that prevent other states from penalizing individuals for actions permitted by this bill.

Health and Social Services, Justice

https://iga.in.gov/legislative/2026/bills/senate/236/details